Talk to our Consultant - Digital Biomarker Market Share, Key Competitor and Industry Trends, 2025

Global Digital Biomarker Market Analysis, 2020

By Type (Clinical Trials, Clinical Settings), By Data Collection (Wearables, Biosensors, Mobile Apps, Devices & Platforms, Desktop Based Software), By Application (Sleep & Movement, Cardiovascular, Pa... ... , Cardiovascular, Pain Management, Mood & Behavior, Neurodegenerative Disorders, Respiratory Ailment), By End-User (Biopharma Firms, Payers, Providers), By Region (North America, South America, Europe, Asia-Pacific, Middle East & Africa), By Country (US, Canada, Mexico, Brazil, UK, Germany, Italy, France, Spain, Russia, Scandinavia, The Netherland, China, Japan, Singapore, South Korea, India, Australia, GCC) Read more

Healthcare
Jun 2020
Pages 187
Report Format: PDF, Excel, PPT

Digital Biomarkers refer to the data which collected about health for earlier detection and prevention of diseases. The Global Digital Biomarker Market Analysis, 2020 research report depicts a deep-dive market analysis of statistics of Global Digital Biomarker market which consists of regional and country-wise market size, market forecast, CAGR market segmentation, market shares of diverse regions and countries, market share of various end users, applications, product type, technologies, competitive benchmarking, etc.

According to MarkNtel Advisors’ research report “Global Digital Biomarker Market Analysis, 2020”, the Global Digital Biomarker market is anticipated to grow at a CAGR of around 42 % during 2020-25. Based on end user, Biopharma segment accounted for the highest portion in the Global Digital Biomarker market share in 2019. However, it is projected that the health insurance payers’ segment would foresee growth at the highest rate in the forecast period on an account of rising usage of the digital biomarkers by payer companies to efficiently develop customized care plans.

Pain Management Accounted for a Significant Market Share
Based on application, pain management held the considerable market share in the Global Digital Biomarker market in 2019 on an account of technological advancements in healthcare and adoption of 4th generation technologies such as AR/VR solutions which are used for the detection and treatment of chronic pain. However, the cardiovascular segment is also projected to proliferate in the forecast period due to rise in cardiovascular diseases (CVDs) worldwide as stated in the MarkNtel Advisors’ research report “Global Digital Biomarker Market Analysis, 2020”.

According to MarkNtel Advisors, the key players with a considerable market share in the Global Digital Biomarker market include Bayer AG, AliveCor Inc, Altoida Inc, Akili Interactive Labs, Actigraph LLC, Biogen Inc, Eli Lily, Evidation Health, GSK PLC, Fitbit Inc, Human API, Happify Health, IXICO PLC, Neurotrack Technology, Novartis, Pfizer, F. Hoffman- La Roche, Takeda Pharmaceuticals, Amgen Inc, Verily Life Sciences etc. To gain competitive advantage over the other market players, these companies are continuously raising funds to introduce new technologies in the healthcare sector.

Introduction
1. Product Definition
2. Research Process
3. Assumptions
4. Market Segmentation
Executive Summary
Global Digital Biomarker Start-Up Ecosystem, 2015-2020
Global Digital Biomarker Market Overview
1. Type of Biomarkers
2. Application Areas
3. Innovations
Global Digital Biomarker Market Technology Integration
1. Artificial Intelligence
2. Immersive Technologies
3. Cloud Computing
4. Edge Computing
5. Blockchain
Impact of COVD-19 on Global Biomarkers Market
Expert Verbatim- Interview Excerpts of Industry Experts
Global Digital Biomarkers Market Outlook, 2015-2025F
1. Market Size & Analysis
  1. By Revenues
2. Market Share & Analysis
  1. By Type
    1. Clinical Trials
    2. Clinical Settings
  2. By Data Collection System
    1. Wearables
    2. Biosensors
    3. Mobile Apps
    4. Devices & Platforms
    5. Desktop Based Software
  3. By Application
    1. Sleep & Movement
    2. Cardiovascular
    3. Pain Management
    4. Mood & Behavior
    5. Neurodegenerative Disorders
    6. Respiratory Ailment
  4. By End Users
    1. Biopharma Firms
    2. Payers
    3. Providers
  5. By Region
    1. North America
      1. The US
      2. Canada
      3. Mexico
    2. South America
      1. Brazil
      2. Rest of South America
    3. Europe
      1. Germany
      2. The UK
      3. France
      4. Italy
      5. Spain
      6. The Netherlands
      7. Russia
      8. Scandinavia
      9. Rest of Europe
    4. Asia Pacific
      1. China
      2. Japan
      3. India
      4. South Korea
      5. Australia
      6. Singapore
      7. Rest of Asia Pacific
    5. Middle East & Africa
      1. GCC
      2. Rest of MEA
North America Digital Biomarkers Market Outlook, 2015-2025F
1. Market Size & Analysis
  1. By Revenues
2. Market Share & Analysis
  1. By Type
  2. By Data Collection System
  3. By Application
  4. By End Users
  5. By Country
    1. The US
    2. Canada
    3. Mexico
3. North America Digital Biomarkers Growth Drivers & Challenges
4. The US Digital Biomarkers Market Outlook, 2015-2025F
  1. The US Digital Health Ecosystem
  2. Market Size & Analysis
    1. By Revenues
  3. Market Share & Analysis
    1. By Type
    2. By Data Collection System
    3. By Application
  4. The US Digital Biomarker Market Regulations
5. Canada Biomarkers Market Outlook, 2015-2025F
  1. Canada Digital Health Ecosystem
  2. Market Size & Analysis
    1. By Revenues
  3. Market Share & Analysis
    1. By Type
    2. By Data Collection System
    3. By Application
  4. Canada Digital Biomarker Market Regulations
6. Mexico Digital Biomarkers Market Outlook, 2015-2025F
  1. The US Digital Health Ecosystem
  2. Market Size & Analysis
    1. By Revenues
  3. Market Share & Analysis
    1. By Type
    2. By Data Collection System
    3. By Application
  4. Mexico Digital Biomarker Market Regulations
South America Digital Biomarkers Market Outlook, 2015-2025F
1. Market Size & Analysis
  1. By Revenues
2. Market Share & Analysis
  1. By Type
  2. By Data Collection System
  3. By Application
  4. By End Users
  5. By Country
    1. Brazil
    2. Others
3. Brazil Digital Biomarkers Market Outlook, 2015-2025F
  1. Germany Digital Health Ecosystem
  2. Market Size & Analysis
    1. By Revenues
  3. Market Share & Analysis
    1. By Type
    2. By Data Collection System
    3. By Application
Europe Digital Biomarkers Market Outlook, 2015-2025F
1. Market Size & Analysis
  1. By Revenues
2. Market Share & Analysis
  1. By Type
  2. By Data Collection System
  3. By Application
  4. By End Users
  5. By Country
    1. Germany
    2. The UK
    3. France
    4. Italy
    5. Spain
    6. The Netherlands
    7. Russia
    8. Scandinavia
    9. Rest of Europe
3. Europe Digital Biomarkers Growth Drivers & Challenges
4. Germany Digital Biomarkers Market Outlook, 2015-2025F
  1. Germany Digital Health Ecosystem
  2. Market Size & Analysis
    1. By Revenues
  3. Market Share & Analysis
    1. By Type
    2. By Data Collection System
    3. By Application
5. France Biomarkers Market Outlook, 2015-2025F
  1. France Digital Health Ecosystem
  2. Market Size & Analysis
    1. By Revenues
  3. Market Share & Analysis
    1. By Type
    2. By Data Collection System
    3. By Application
6. The UK Digital Biomarkers Market Outlook, 2015-2025F
  1. Italy Digital Health Ecosystem
  2. Market Size & Analysis
    1. By Revenues
  3. Market Share & Analysis
    1. By Type
    2. By Data Collection System
    3. By Application
7. Spain Digital Biomarkers Market Outlook, 2015-2025F
  1. Spain Digital Health Ecosystem
  2. Market Size & Analysis
    1. By Revenues
  3. Market Share & Analysis
    1. By Type
    2. By Data Collection System
    3. By Application
8. Italy Digital Biomarkers Market Outlook, 2015-2025F
  1. Italy Digital Health Ecosystem
  2. Market Size & Analysis
    1. By Revenues
  3. Market Share & Analysis
    1. By Type
    2. By Data Collection System
    3. By Application
9. The Netherlands Digital Biomarkers Market Outlook, 2015-2025F
  1. The Netherlands Digital Health Ecosystem
  2. Market Size & Analysis
    1. By Revenues
  3. Market Share & Analysis
    1. By Type
    2. By Data Collection System
    3. By Application
10. Russia Digital Biomarkers Market Outlook, 2015-2025F
  1. Russia Digital Health Ecosystem
  2. Market Size & Analysis
    1. By Revenues
  3. Market Share & Analysis
    1. By Type
    2. By Data Collection System
    3. By Application
11. Scandinavia Digital Biomarkers Market Outlook, 2015-2025F
  1. Scandinavia Digital Health Ecosystem
  2. Market Size & Analysis
    1. By Revenues
  3. Market Share & Analysis
    1. By Type
    2. By Data Collection System
    3. By Application
Asia Pacific Digital Biomarkers Market Outlook, 2015-2025F
1. Market Size & Analysis
  1. By Revenues
2. Market Share & Analysis
  1. By Type
  2. By Data Collection System
  3. By Application
  4. By End Users
  5. By Country
    1. China
    2. Japan
    3. South Korea
    4. India
    5. Singapore
    6. Australia
    7. Rest of APAC
3. Asia Pacific Digital Biomarkers Growth Drivers & Challenges
4. China Digital Biomarkers Market Outlook, 2015-2025F
  1. China Digital Health Ecosystem
  2. Market Size & Analysis
    1. By Revenues
  3. Market Share & Analysis
    1. By Type
    2. By Data Collection System
    3. By Application
5. Japan Digital Biomarkers Market Outlook, 2015-2025F
  1. Japan Digital Health Ecosystem
  2. Market Size & Analysis
    1. By Revenues
  3. Market Share & Analysis
    1. By Type
    2. By Data Collection System
    3. By Application
6. South Korea Digital Biomarkers Market Outlook, 2015-2025F
  1. South Korea Digital Health Ecosystem
  2. Market Size & Analysis
    1. By Revenues
  3. Market Share & Analysis
    1. By Type
    2. By Data Collection System
    3. By Application
7. India Digital Biomarkers Market Outlook, 2015-2025F
  1. India Digital Health Ecosystem
  2. Market Size & Analysis
    1. By Revenues
  3. Market Share & Analysis
    1. By Type
    2. By Data Collection System
    3. By Application
8. Singapore Digital Biomarkers Market Outlook, 2015-2025F
  1. Singapore Digital Health Ecosystem
  2. Market Size & Analysis
    1. By Revenues
  3. Market Share & Analysis
    1. By Type
    2. By Data Collection System
    3. By Application
9. Australia Digital Biomarkers Market Outlook, 2015-2025F
  1. Australia Digital Health Ecosystem
  2. Market Size & Analysis
    1. By Revenues
  3. Market Share & Analysis
    1. By Type
    2. By Data Collection System
    3. By Application
Middle East & Africa Digital Biomarkers Market Outlook, 2015-2025F
1. Market Size & Analysis
  1. By Revenues
2. Market Share & Analysis
  1. By Type
  2. By Data Collection System
  3. By Application
  4. By End Users
  5. By Country
    1. GCC
    2. Others (Mention names)
3. Middle East & Africa Digital Biomarkers Growth Drivers & Challenges
4. GCC Digital Biomarkers Market Outlook, 2015-2025F
  1. GCC Digital Health Ecosystem
  2. Market Size & Analysis
    1. By Revenues
  3. Market Share & Analysis
    1. By Type
    2. By Data Collection System
    3. By Application
Global Digital Biomarkers Market Dynamics
1. Drivers
2. Challenges
3. Impact Analysis
Global Digital Biomarkers Market Trends & Insights
Global Digital Biomarkers Market Regulations, Product Standards
Global Digital Biomarkers Market Case Studies
1. Parkinson
2. Alzheimer
3. Cardiovascular
4. Others
Global Digital Biomarkers Market Intellectual Property Rights Analysis
Global Digital Biomarkers Market Hotspots & Opportunities
Competition Outlook
1. Competitor Wise Growth Strategies
  1. Product Portfolio
  2. Financial Information
  3. Brand Specialization
  4. Target Markets
  5. Research & Development
  6. Strategic Alliances & Initiatives
2. Company Profiles
  1. Bayer AG
  2. AliveCor Inc
  3. Altoida Inc
  4. Akili Interactive Labs
  5. Actigraph LLC
  6. Biogen Inc
  7. Eli Lily
  8. Evidation Health
  9. GSK PLC
  10. Fitbit Inc
  11. Human API
  12. Happify Health
  13. IXICO PLC
  14. Neurotrack Technology
  15. Novartis
  16. Pfizer
  17. F. Hoffman- La Roche
  18. Takeda Pharmaceuticals
  19. Amgen Inc
  20. Verily Life Sciences
Disclaimer

MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

Full Name*:

Company Name*:

Business Email*:

Country Name*:

Contact Number*:

Message:

Flexible Licensing Options

We offer flexible licensing options to cater to varying organizational needs. Choose the pricing pack that best suits your requirements:

Buy Now

Inquire Before Buying